Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0002072045-25-000006
Filing Date
2025-06-30
Accepted
2025-06-30 10:26:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5287
  Complete submission text file 0002072045-25-000006.txt   7134
Mailing Address 55 UNIVERSITY AVENUE, SUITE 1003 TORONTO Ontario, Canada M5J 2H7
Business Address 55 UNIVERSITY AVENUE, SUITE 1003 TORONTO Ontario, Canada M5J 2H7 (416) 854-8884
Quantum Biopharma Ltd. (Subject) CIK: 0001771885 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91661 | Film No.: 251089346
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9201 W STATE ST. STE 126 BOISE ID 83714
Business Address 9201 W STATE ST. STE 126 BOISE ID 83714 2089854526
Malone Wealth Ventures LLC (Filed by) CIK: 0002072045 (see all company filings)

EIN.: 861544286 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A